Operational Research—Tuberculosis Overview
Keywords:
Operational research, tuberculosis, India, COVID-19, communicable diseasesAbstract
The present review outlined the basic information regarding operational research for successful control of communicable diseases in India with its history of origin, objectives, scope, basic approaches, steps, and principles involved. Also the descriptive critical review on burden of communicable diseases such as tuberculosis and COVID-19 burden in India along with present scenario and problems being faced by India over control of communicable diseases in 2020 were also discussed. The present review covered all the possible information regarding operational research which is a distinctive instrument leading to greater benefits for the epidemiologists, health policymakers, health economists, public health specialists to get solutions for the problems and to develop effective methods to solve the problems in timely manner for the relevant problems in public health system, particularly for effective control of communicable diseases.References
Harries AD, Lin Y, Kumar AMV, Satyanarayana S, Takarinda KC, Dlodlo RA, Zachariah R, Olliaro P. What can national T.B control programs in low-and middle-income countries do to end tuberculosis by 2030? F1000 Research. 2018; 7: 1011.
Fisher AA, Laing JE, Stoeckel JE, Townsend JW. Hand Book for Family Planning Operations Research Design, 2nd Ed. New York: Population Council; 1991.
World Health Organization. Framework for operations and implementation research in health. Geneva: WHO; 2018. Available from: http//www.who.int/hiv/pub/operational/frame work/en/Index. Hmtl (accessed on 2015 Apr 4).
Murthy PR. Operational Research. New Delhi: New Age International Publishers; 2007. 1–21p.
Churchman CW, Ackoff RL, Arnoff EL. Introduction to Operations Research. New York: John Wiley & Sons Inc.; 1957.
Zachariah R, Harries AD, Ishikawa N, Rieder HL, Bissell K, Laserson K, Massaquoi M, Herp MV, Reid T. Operational Research in low-income countries What, why and how? Lancet Infect Dis. 2009; 9(7): 11–17p.
Sharma D, Sarkar D. Pathophysiology of Tuberculosis: An Updated Review. Pharmatutor. 2018; 6(2): 15–21p.
Monks T. Operational research as implementation science: Definitions, challenges and research priorities. Implementation Science. 2016; 11: 81. DOCI: 1186/s 13012-016-044-0.
Wang Chen, Horby Peter W, Hayden Frederick G, Gao George F. A novel coronavirus outbreak of global health concern. The Lancet. 2020;395(10223):470–473 https://www.who.int/emergencies/ diseases/novel-coronavirus-2019?gclid=CjwKCAjw0On8BRAgEiwAincsHGeZZlRMAJYcoscb9 uiM3WBnCDZGSVnqwYYnMVAtOqZtY0SbK8HguBoC6fcQAvD_B
Who.int. (2023). 2019 Novel Coronavirus. Online Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=
Padayatchi N, Daftary A, Naidu N, Naidoo K, Pai M. Tuberculosis: Treatment failure, or failure to treat? Lessons from India and South Africa. BMJ Glob Health. 2019; 4(1): e001097.
Pai M, Nicol MP, Boehme CC. Tuberculosis diagnostics: State of the art and future directions. Microbiol Spectr. 2016; 4(5): 7p.
Dash M. Drug resistant tuberculosis: A diagnostic challenge. J Postgrad Med. 2013; 59(3): 196e202.
Thakur H. Drug resistance in TB control—a global & Indian situation. J Prevent Med. 2008; 16(3e4): 3e9.
Sharma N, Khanna A, Chandra S, Basu S, Chopra KK, Singla N, Babbar N, Kohli C. Trends & treatment outcomes of multidrug-resistant tuberculosis in Delhi, India (2009-2014): a retrospective record-based study. Indian J Med Res. 2020; 151(6): 598e603.
Rawal T, Butani S. Combating tuberculosis infection: a forbidding challenge. Indian J Pharmaceut Sci. 2016; 78(1): 8e16.
Pai M, Furin J. Tuberculosis innovations mean little if they cannot save lives. eLife. 2017; 6: e25956.
Khaparde S. The national strategic plan for tuberculosis step toward ending tuberculosis by 2025. J Mahatma Gandhi Inst Med Sci. 2019; 24: 17e18.
Zachariah R, Spielmann MP, Chinji C, Gomani P, Arendt V, Hargreaves NJ, Salaniponi FM, Harries AD. Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi. AIDS. 2003; 17: 1053–1061p.
Sai Babu B, Satyanarayana AV, Venkateshwaralu G, Ramakrishna U, Vikram P, Sahu S, Wares F, Dewan PK, Santosha K, Jyoti J, Srinath S, Chethana R, Neelima T, Vinod P, Yogesh M. Initial default among diagnosed sputum positive pulmonary tuberculosis patients in Andhra Pradesh, India. Int J Tuberc Lung Dis. 2008; 12: 1055–1058p.
Dr. Gunjan Kumar Public Health Panorama of Operational Research: A Narrative Review International journal of preventive medicine. 2019; 10: 43.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |